Skip to main content

Table 1 Statistical analysis of secondary outcomes

From: Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial

Evolution of score (end of the period - beginning of the period) Polyphenon E® Mean ± SD (N) Placebo Mean ± SD (N) p value
Surface area - 4.07 ± 7.62 (12) - 4.42 ± 9.84 (14) 0.93
Skin fragility - 0.90 ± 2.46 (12) - 0.64 ± 2.06 (14) 0.75
Mucosal involvement 0.55 ± 1.12 (8) 1.97 ± 1.64 (6) 0.07
Itch - 1.17 ± 3.53 (12) 0 ± 2.16 (14) 0.38
Mean duration of wound healing (days) -14.62 ± 18.76 (7) 1.78 ± 14.65 (9) 0.21
  1. N number of patients, SD standard deviation